Ventricular aneurysms are circumscribed, thin-walled fibrous, noncontr
actile outpouchings of the ventricle. The majority are apically locate
d, true aneurysms of the left ventricle (LV) that occur as a consequen
ce of transmural myocardial infarction (MI). The precursor of aneurysm
formation appears to be infarct expansion early after acute MI and oc
currence generally relates to infarct size. The presence of underlying
hypertension and the use of steroids and nonsteroidal anti-inflammato
ry agents may promote aneurysm formation. The clinical sequelae includ
e congestive heart failure (CHF), thromboembolism, angina pectoris, an
d ventricular tachyarrhythmias. Late rupture is a particular complicat
ion of false aneurysms in which the pericardium is the aneurysm wall.
The diagnosis may be suspected by the clinical finding of a diffuse, p
ansystolic apical thrust, persistent ST-segment elevation on the elect
rocardiogram, and distortion of the cardiac silhouette on chest x-ray.
This can be confirmed using echocardiography, radionuclide ventliculo
graphy, and cardiac catheterization, The latter has the additional adv
antage of being able to delineate the coronary anatomy, Management inv
olves prevention, specific therapy for the various clinical manifestat
ions, and surgery. Therapeutic interventions with thrombolytic agents,
aspirin, heparin, and beta blockers that are applied early in the evo
lution of an MI may limit infarction size, thereby reducing the tenden
cy toward infarct expansion and aneurysm formation. Patients with mild
CHF can usually be controlled with the standard combination of angiot
ensin-converting enzyme inhibitors, diuretics, and digoxin. Thromboemb
olism is best prevented by anticoagulation with warfarin for at least
3 months after the acute MI. The choice of pharmacotherapy for ventric
ular tachyarrhythmias should be guided by electro-physiologic studies,
The treatment of patients with angina pectoris utilizes conventional
therapeutic modalities. Refractory angina and high-risk coronary anato
mic subsets have replaced CHF as the commonest indications for surgica
l intervention in recent studies. In these patients, aneurysmectomy is
often performed as an aside to the primary revascularization procedur
e. Although aneurysmectomy may improve the functional status and eject
ion fraction of some patients with CHF, its effect on prognosis is les
s certain. The prognostic advantage of surgery appears to be related m
ore to coronary revascularization than to the aneurysm resection per s
e.